These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7049439)

  • 1. The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangement.
    Madsbad S; Faber OK; Kurtz A; Krarup T; Regeur L; Tronier B; Orskov H; Binder C; Alberti KG
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):605-13. PubMed ID: 7049439
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal and metabolic effects of a pancreatic endocrine graft. Vascularized segmental transplantation in insulin-dependent diabetic patients.
    Sutherland DE; Najarian JS; Greenberg BZ; Senske BJ; Anderson GE; Francis RS; Goetz FC
    Ann Intern Med; 1981 Nov; 95(5):537-41. PubMed ID: 6794405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate.
    Robertson RP; Chen M
    Trans Assoc Am Physicians; 1977; 90():353-65. PubMed ID: 347676
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.
    Lauritzen T; Binder C; Faber OK
    Acta Paediatr Scand Suppl; 1980; 283():81-5. PubMed ID: 7010905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic consequences of insulin deficiency].
    Lefebvre PJ; Luyckx AS; Scheen AJ; Castillo M; Jandrain B; Krzentowski G
    Journ Annu Diabetol Hotel Dieu; 1984; ():163-74. PubMed ID: 6152663
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic changes in the islets of Langerhans in relationship to the onset of diabetes mellitus.
    Taylor KW
    Diabetologia; 1972 Aug; 8(4):236-43. PubMed ID: 4564647
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin secretion and the development of diabetes mellitus in the adult.
    Cerasi E; Luft R
    Acta Med Scand Suppl; 1976; 601():111-48. PubMed ID: 16981322
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.
    Lutterman JA; Benraad TJ; van 't Laar A
    Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes.
    Polonsky KS; Semenkovich CF
    Cell; 2001 Jun; 105(6):705-7. PubMed ID: 11440712
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiology of insulin secretion: problems of quantity and timing.
    Matthews DR; Connolly AA; Holman RR; Turner RC
    Neth J Med; 1985; 28 Suppl 1():20-4. PubMed ID: 3892333
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin secretion following administration of secretin in patients with diabetes mellitus.
    Deckert T
    Acta Endocrinol (Copenh); 1968 Sep; 59(1):150-8. PubMed ID: 4884927
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral antidiabetic therapy.
    Melander A; Almér LO; Sartor G; Scherstén B; Wåhlin-Boll E
    Acta Med Scand Suppl; 1981; 656():55-7. PubMed ID: 7046351
    [No Abstract]   [Full Text] [Related]  

  • 15. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variations of basal and post-stimulative insulin blood levels, during prolonged treatment with hypoglycemic sulfamides].
    Pirart J; Lauvaux JP; Mandart G
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):67-79. PubMed ID: 4606062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of insulin receptors in the pathogenesis and treatment of diabetes].
    Lenti G; Pagano G; Cassader M
    Journ Annu Diabetol Hotel Dieu; 1978; ():73-86. PubMed ID: 349230
    [No Abstract]   [Full Text] [Related]  

  • 18. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
    Zhou YP; Grill V
    J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexercise dose-response relationship between plasma glucose and insulin secretion.
    Mikines KJ; Farrell PA; Sonne B; Tronier B; Galbo H
    J Appl Physiol (1985); 1988 Mar; 64(3):988-99. PubMed ID: 3284873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin secretion and its control].
    Koivisto V
    Duodecim; 1975; 91(8):511-20. PubMed ID: 166815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.